Novo Nordisk Sinks on Obesity Drug Study's Disappointing Results
Novo Nordisk's U.S.-listed shares lost ground Friday after a study of the pharmaceutical firm’s latest obesity treatment ...
FTC sues OptumRx, rivals over insulin pricing
UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
The American Journal of Managed Care35m
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...
GoLocalProv46m
FTC Sues Prescription Drug Middlemen Including CVS for Artificially Inflating Insulin Drug Prices
The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx ...
Challenge to US drug price negotiation program revived by appeals court
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...
The Washington Post on MSN51m
FTC sues pharmacy insurance managers, alleging unfair drug prices
The FTC said that PBMs aren’t necessarily the only ones to blame for high insulin prices, and that its Bureau of Competition “remains deeply troubled by the role of drug manufacturers” including Eli ...
Nvidia: Valuation Remains Justified Despite Potential Margin Normalization And Revenue Decay From China
NVDA's Q2 2025 growth driven by the Data Center segment, geopolitical concerns with China may impact revenue, but upside ...